Jean-Marc Le Doussal – Serial entrepreneur in biotechnology & venture investor – Lausanne, Waadt, Schweiz | LinkedIn
Jean-Marc Le Doussal email address & phone number | Remora Capital Founder and Chief Executive Officer contact information - RocketReach
Jean-Marc Le Doussal email address & phone number | Remora Capital Founder and Chief Executive Officer contact information - RocketReach
Jean-Marc Le Doussal – Serial entrepreneur in biotechnology & venture investor – Lausanne, Waadt, Schweiz | LinkedIn
Jean-Marc Le Doussal – Serial entrepreneur in biotechnology & venture investor – Lausanne, Waadt, Schweiz | LinkedIn
Jean-Marc Le Doussal – Serial entrepreneur in biotechnology & venture investor – Lausanne, Waadt, Schweiz | LinkedIn
Antiâ•'idiotypic monoclonal antibody AB3, reacting with the primary antigen (CEA), can localize in human colonâ•'carci
Intracellular uptake and catabolism of antiâ•'IgM antibodies and BIâ•'specific antibodyâ•'targeted hapten by Bâ
Jean-Marc Le Doussal – Serial entrepreneur in biotechnology & venture investor – Lausanne, Waadt, Schweiz | LinkedIn
![Pretargeted Radioimmunotherapy of Human Colorectal Xenografts with Bispecific Antibody and 131I-Labeled Bivalent Hapten | Journal of Nuclear Medicine Pretargeted Radioimmunotherapy of Human Colorectal Xenografts with Bispecific Antibody and 131I-Labeled Bivalent Hapten | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/41/3/480.extract.jpg)
Pretargeted Radioimmunotherapy of Human Colorectal Xenografts with Bispecific Antibody and 131I-Labeled Bivalent Hapten | Journal of Nuclear Medicine
![Jean-Marc Le Doussal email address & phone number | Remora Capital Founder and Chief Executive Officer contact information - RocketReach Jean-Marc Le Doussal email address & phone number | Remora Capital Founder and Chief Executive Officer contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/amin-shokrollahi-13cd3ff1.jpg)
Jean-Marc Le Doussal email address & phone number | Remora Capital Founder and Chief Executive Officer contact information - RocketReach
![Delivery of Therapeutic Doses of Radioiodine Using Bispecific Antibody-Targeted Bivalent Haptens | Journal of Nuclear Medicine Delivery of Therapeutic Doses of Radioiodine Using Bispecific Antibody-Targeted Bivalent Haptens | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/39/11/1937.extract.jpg)